In other studies, it was shown that MCC950 could effectively alleviate diabetes-induced renal damage by inhibiting the NLRP3/Caspase-1 pathway, which may be a potential therapeutic strategy for preventing the progression of diabetic nephropathy [39]. Here, NLRP3 is linked to diabetes mellitus.